Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pavitt (Billingshurst (West Sussex), United Kingdom), S. Krivinskas (Billingshurst (West Sussex), United Kingdom), J. Congleton (Billingshurst (West Sussex), United Kingdom), S. Hippolyte (Billingshurst (West Sussex), United Kingdom). SARS-CoV-2: Survival in COPD phenotypes. 4195

Member's Comments

No comment yet.

Related content which might interest you: COPD phenotypes Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 COPD phenotypes Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 Stability of COPD phenotypes over time Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Survival characteristics and predictors of mortality in COPD subjects Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Survival following pulmonary rehabilitation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 209s Year: 2004 Tree years survival rates of COPD patients that hospitalized for acute excecerbation of COPD Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Multicomponent indices to predict survival in COPD: the COCOMICS study Source: Eur Respir J 2013; 42: 323-332 Year: 2013 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Clinical COPD phenotypes identified by cluster analysis: validation with mortality Source: Eur Respir J 2012; 40: 495-496 Year: 2012 Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype? Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 COPD Phenotypes and Comorbidities Source: International Congress 2017 – COPD biomarkers Year: 2017 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016